🕒 Last update: loading…

Stock Lichen International Limited LICN

Lichen International Limited — Investlytic score 1/5 on the five criteria.

-
-
20/ 100
Score Investlytic · 5 criteria

Analysis in progress…

Investlytic score: 1/5 criteria met.

  • ❌ Price trend failed
  • ❌ Growth failed
  • ✅ Debt passed
  • ❌ P/E failed
  • ❌ Correction failed

Price trend

Overall trend (8 years): insufficient progression (less than x1.5).

Price change 2023 → 2024: -91.03%

Price change 2024 → 2025: -92.06%

Price change 2025 → 2026: -63.48%

Price change 2026 (year to date): -64.60%

Financial growth

Revenue CAGR (8 years): -0.53%

Earnings CAGR (8 years): N/A

Growth status: insufficient data or negative trend.

Debt

Debt-to-equity ratio: 0.01

Debt/equity < 0.5 (maximum threshold).

P/E (Price/Earnings)

P/E ratio: -1.30

P/E > 25.0 (maximum threshold).

Correction (6 months)

Current correction: 88.06% from the high over 6 months.

Excessive correction (> 20.0%).

WATCH
The stock is currently being evaluated.

Criteria of the Investlytic model

- / 5
🔒

Investlytic rating reserved for members

Score out of 100, model verdict (buy, watch, sell) and details of the 5 criteria · visible with a free account.

02

Price trend

Price & trend

Interactive chart →
Loading chart…

⚖️ Comparison with the market

All stocks →
StockP/EDette/FPRevenue growthRating
Lichen International Limited–0.01+9.2 %🔒
BOA Concept SAS5.20.53+22.7 %–
BSA Limited3.20.23−13.8 %–
Grolleau S.A.–0.49+5.0 %–
Tractial10.02.05−7.8 %–

Data from the Investlytic screener. The rating of the stock being viewed is reserved for members.

03

Detailed analysis · Price trend

-

🔒

Reserved for members

Global model trend and annual price variations · visible with a free account.

04

Revenues & profits

Revenue and net income

🔒

Reserved for members

Chart of revenues and net income over 8 periods · real data, no estimates.

05

Financial indicators

🔒

Reserved for members

18 financial indicators analyzed by groups of criteria: valuation, profitability, growth, solidity, dividend, and momentum.

06

Annual financial statements

Fiscal yearRevenueNet income Net marginEPSRevenue growth
🔒

Reserved for members

Complete annual financial statements: revenue, net income, margin, and EPS over 8 fiscal years.

+

Key reported figures

Revenue, net income and net margin reported by Lichen International Limited over the latest fiscal years.

Revenue
24.5 m USD
fiscal year 2025
Net income
-22.0 m USD
fiscal year 2025
Net margin
-89.6 %
fiscal year 2025
Average annual growth
-4.4 %
Revenue growth over 5 years
Average annual growth
+10.2 %
Revenue growth over 10 years
Market cap
8.3 m USD
Fiscal yearRevenueNet incomeNet marginRevenue growth
202030.7 m6.4 m20.9 %n/a
202134.3 m8.5 m24.7 %+11.8 %
202233.8 m7.8 m23.1 %-1.4 %
202339.8 m8.3 m21.0 %+17.6 %
202441.5 m-6.1 m-14.8 %+4.3 %
202524.5 m-22.0 m-89.6 %-40.9 %

Amounts converted to USD. Source: published annual accounts, collected on 06/11/2026.

+

Accounts and financial health

Balance sheet and cash flow published by Lichen International Limited over the last fiscal years, strength scores and valuation by discounted cash flow (DCF).

Overview
fragile accounts
according to Altman Z, Piotroski and net debt
Altman Z-score
1.11
risk zone (below 1.81)
Piotroski Score
1 / 9
0 to 3: fragile accounts
Net Debt / EBITDA
1.50 x
moderate debt
Fiscal year20212022202320242025
Cash and investments16.8 m22.6 m25.9 m26.7 m26.9 m
Total Debt345,000272,000129,00061,000554,000
Net Debt-16.5 m-22.3 m-25.7 m-26.7 m-26.4 m
Equity36.8 m41.1 m61.4 m73.2 m70.5 m
Total assets42.9 m46.5 m65.5 m79.8 m75.6 m
Operating cash flow7.3 m10.8 m557,000-5.6 m-17.8 m
Investments (capex)28,0002.8 m5.3 m36,0000
Free cash-flow7.3 m7.9 m-2.6 m-11.5 m-17.8 m
Share buybacks00000
Dividends paid00000

Amounts in USD, currency of the published accounts.

Trailing 12-month ratios

Price / earnings (P/E)-0.34 x
Price / book value0.14 x
Return on Equity (ROE)-36.8 %
Return on Invested Capital (ROIC)-29.1 %
Net margin-117.7 %
Debt / equity0.00 x
Current ratio5.81 x
Free cash-flow yield-193.2 %

Altman Z: default risk estimated from the balance sheet and earnings. Piotroski: 9 tests on profitability, debt and efficiency. DCF: estimated value from discounted future cash flows, a model and not a forecast. Source: annual accounts published by the company, data as of 09/11/2026.

+

PEA and practical information

PEA eligibility
no
head office outside the EU and EEA
Listing exchange
Nasdaq
IPO: 06/02/2023
ISIN code
KYG5479G1165
Workforce
452
full-time employees
Chief executive
Ya Li

Rule applied: the French PEA accepts shares of companies headquartered in the European Union or the European Economic Area and subject to corporate income tax; ADRs and tax-exempt property companies (SIIC) are excluded. The institution holding the PEA confirms eligibility.

?

Frequently asked questions about Lichen International Limited

What is the Lichen International Limited share price?

Latest recorded price: 0.510 USD on 06/11/2026, for a market cap of 8.3 m USD.

What is the revenue of Lichen International Limited?

24.5 m USD for fiscal year 2025, with net income of -22.0 m USD (net margin -89.6 %).

Is Lichen International Limited stock eligible for the French PEA?

No: the company is headquartered outside the European Union and the European Economic Area (ISIN KYG5479G1165).

How many employees does Lichen International Limited have?

452 full-time employees according to the latest published profile.

Who runs Lichen International Limited?

Ya Li is the company's chief executive.

07

Similar stocks